With no clinical trials conducted in Africa, researchers have emphasized that Africa's Covid-19 research should be tailored to the continent's realities.
While some African countries, Nigeria, Zambia, Tunisia and Egypt are involved in the global Solidarity Clinical Trials, the continent needs support to develop its medicinal research potential, improve efficacy and quality as well as and encourage best medical practices.
Following the Malagasy Institute's Covid-19 drink, WHO's calls, reinforced by US Centers for Disease Control, urged people not to try the untested remedy arguing that Africans deserve to use medicines at the same standards as people in the rest of the world.
Thus, like other medicines, Hydroxychloroquine and azithromycin were tested as part of Covid-19 treatment trials, so too should COVID-ORGANICS have been given the chance to allow a scientific and non-emotional rejection.
Indeed, until 12 May 2020 when the WHO agreed to clinical trials of COVID-ORGANICS, President Rajoelina had criticized the West for a condescending attitude towards traditional medicine in Africa.
